199 related articles for article (PubMed ID: 23674869)
1. CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells.
Kósa JP; Horváth P; Wölfling J; Kovács D; Balla B; Mátyus P; Horváth E; Speer G; Takács I; Nagy Z; Horváth H; Lakatos P
World J Gastroenterol; 2013 May; 19(17):2621-8. PubMed ID: 23674869
[TBL] [Abstract][Full Text] [Related]
2. Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer.
Höbaus J; Hummel DM; Thiem U; Fetahu IS; Aggarwal A; Müllauer L; Heller G; Egger G; Mesteri I; Baumgartner-Parzer S; Kallay E
Int J Cancer; 2013 Sep; 133(6):1380-8. PubMed ID: 23463632
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones.
Aboraia AS; Makowski B; Bahja A; Prosser D; Brancale A; Jones G; Simons C
Eur J Med Chem; 2010 Oct; 45(10):4427-34. PubMed ID: 20655626
[TBL] [Abstract][Full Text] [Related]
4. The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis.
Horváth HC; Lakatos P; Kósa JP; Bácsi K; Borka K; Bises G; Nittke T; Hershberger PA; Speer G; Kállay E
J Histochem Cytochem; 2010 Mar; 58(3):277-85. PubMed ID: 19901270
[TBL] [Abstract][Full Text] [Related]
5. Wavelength-dependent induction of CYP24A1-mRNA after UVB-triggered calcitriol synthesis in cultured human keratinocytes.
Bär M; Domaschke D; Meye A; Lehmann B; Meurer M
J Invest Dermatol; 2007 Jan; 127(1):206-13. PubMed ID: 16902422
[TBL] [Abstract][Full Text] [Related]
6. Chronic ethanol consumption leads to disruption of vitamin D3 homeostasis associated with induction of renal 1,25 dihydroxyvitamin D3-24-hydroxylase (CYP24A1).
Shankar K; Liu X; Singhal R; Chen JR; Nagarajan S; Badger TM; Ronis MJ
Endocrinology; 2008 Apr; 149(4):1748-56. PubMed ID: 18162528
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of the 1,25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1) in colon cancer cells.
Höbaus J; Fetahu ISh; Khorchide M; Manhardt T; Kallay E
J Steroid Biochem Mol Biol; 2013 Jul; 136():296-9. PubMed ID: 22940288
[TBL] [Abstract][Full Text] [Related]
8. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
[TBL] [Abstract][Full Text] [Related]
9. Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells.
Iglesias-Gato D; Zheng S; Flanagan JN; Jiang L; Kittaka A; Sakaki T; Yamamoto K; Itoh T; Lebrasseur NK; Norstedt G; Chen TC
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):269-75. PubMed ID: 21911059
[TBL] [Abstract][Full Text] [Related]
10. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
11. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
12. CYP24A1 inhibition enhances the antitumor activity of calcitriol.
Muindi JR; Yu WD; Ma Y; Engler KL; Kong RX; Trump DL; Johnson CS
Endocrinology; 2010 Sep; 151(9):4301-12. PubMed ID: 20591973
[TBL] [Abstract][Full Text] [Related]
13. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.
Wierzbicka JM; Binek A; Ahrends T; Nowacka JD; Szydłowska A; Turczyk Ł; Wąsiewicz T; Wierzbicki PM; Sądej R; Tuckey RC; Slominski AT; Chybicki J; Adrych K; Kmieć Z; Żmijewski MA
Int J Oncol; 2015 Sep; 47(3):1084-96. PubMed ID: 26260259
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.
Luo W; Yu WD; Ma Y; Chernov M; Trump DL; Johnson CS
Cancer Res; 2013 Apr; 73(7):2289-97. PubMed ID: 23358686
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
Kane KF; Langman MJ; Williams GR
Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982
[TBL] [Abstract][Full Text] [Related]
17. Androgen enhances the antiproliferative activity of vitamin D3 by suppressing 24-hydroxylase expression in LNCaP cells.
Lou YR; Tuohimaa P
J Steroid Biochem Mol Biol; 2006 Apr; 99(1):44-9. PubMed ID: 16524720
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma.
Urbschat A; Paulus P; von Quernheim QF; Brück P; Badenhoop K; Zeuzem S; Ramos-Lopez E
Eur J Clin Invest; 2013 Dec; 43(12):1282-90. PubMed ID: 24245571
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies.
Tannour-Louet M; Lewis SK; Louet JF; Stewart J; Addai JB; Sahin A; Vangapandu HV; Lewis AL; Dittmar K; Pautler RG; Zhang L; Smith RG; Lamb DJ
FASEB J; 2014 Jan; 28(1):364-72. PubMed ID: 24081904
[TBL] [Abstract][Full Text] [Related]
20. CYP24A1 Inhibition Facilitates the Antiproliferative Effect of 1,25(OH)
Sun H; Jiang C; Cong L; Wu N; Wang X; Hao M; Liu T; Wang L; Liu Y; Cong X
DNA Cell Biol; 2018 Sep; 37(9):742-749. PubMed ID: 30052060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
